<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="http://www.skipogh.ch/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-gb">
		<id>http://www.skipogh.ch/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Gehret</id>
		<title>SkiPOGH - User contributions [en-gb]</title>
		<link rel="self" type="application/atom+xml" href="http://www.skipogh.ch/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Gehret"/>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Special:Contributions/Gehret"/>
		<updated>2026-05-09T02:54:07Z</updated>
		<subtitle>User contributions</subtitle>
		<generator>MediaWiki 1.19.2</generator>

	<entry>
		<id>http://www.skipogh.ch/index.php/News</id>
		<title>News</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/News"/>
				<updated>2013-11-28T17:58:24Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&lt;br /&gt;
In total our first visit included '''1,134 participants.'''&lt;br /&gt;
&lt;br /&gt;
October 2012: '''The second study follow-up visit''' of the study (follow-up with additional exams) begins.&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/People</id>
		<title>People</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/People"/>
				<updated>2013-11-08T11:35:01Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Lausanne'''&lt;br /&gt;
&lt;br /&gt;
Prof [[Murielle Bochud]], MD PhD, principal investigator&lt;br /&gt;
&lt;br /&gt;
Prof Michel Burnier, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof [[Fred Paccaud]], MD, investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Menno Pruijm]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Marie-Eve Müller, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Heba Al-Alwan, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Pierre Monney, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Sandrine Estoppey, MSc, coordinator&lt;br /&gt;
&lt;br /&gt;
Mrs Sylvie Tremblay, research nurse&lt;br /&gt;
&lt;br /&gt;
Mrs Güler Gök-Sogut, medical assistant&lt;br /&gt;
&lt;br /&gt;
Mrs [[Jacquier Filomena]], administrative assistant&lt;br /&gt;
&lt;br /&gt;
Mrs Renata Testaz, administrator&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Geneva'''&lt;br /&gt;
&lt;br /&gt;
Prof Pierre-Yves Martin, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof [[Antoinette Pechere | Antoinette Péchère-Bertschi]], MD, investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Belen Ponte]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Idris Guessous, MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr [[Georg Ehret]] MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Yassine Bouatou, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Stéphane Reverdin, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Letizia Conti, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Marie-Odile Lévi, research nurse&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Bern'''&lt;br /&gt;
&lt;br /&gt;
Prof Bruno Vogt, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Markus Mohaupt, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Felix Frey, MD (retired), investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Daniel Ackermann]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Nasser Dahyat, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Ulla Schüpbach, research nurse&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Zurich'''&lt;br /&gt;
&lt;br /&gt;
Prof [[Olivier Devuyst]], MD&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Georg_Ehret</id>
		<title>Georg Ehret</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Georg_Ehret"/>
				<updated>2013-03-22T23:26:41Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:transparent&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Georg Ehret is instructor in cardiology (“Chef de Clinique Scientifique”) and runs a small research laboratory focusing on genomics combined with practice in cardiology at the Geneva University Hospitals.  Georg graduated from the University of Heidelberg and has received his MD thesis from the University of Lausanne.  He is trained in genomics and statistical genetics at the Institute of Genetic Medicine of Johns Hopkins University Baltimore where he holds a part-time faculty appointment. He is also volunteer staff physician (“Médecin agrée bénévole”) at the Community Prevention Unit of the IUMSP in Lausanne.&lt;br /&gt;
&amp;lt;br /&amp;gt; &lt;br /&gt;
His main research interests are the analysis of large-scale genomic datasets, genetic cardiovascular risk prediction, and blood pressure genetics.  Georg is co-convener of several large international genomics consortia working on blood pressure genomics (ICBP, CHARGE-BP).&lt;br /&gt;
&amp;lt;br /&amp;gt; &lt;br /&gt;
[http://www.georgehretlab.org/]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:GeorgEhret.jpg]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/MediaWiki:Sidebar</id>
		<title>MediaWiki:Sidebar</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/MediaWiki:Sidebar"/>
				<updated>2013-03-21T23:45:46Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;#wiki_navigate {font-size:20px;}&lt;br /&gt;
#wiki_navigate a {color: green;}&lt;br /&gt;
&lt;br /&gt;
* navigation&lt;br /&gt;
** News | News&lt;br /&gt;
** Centers | Centers&lt;br /&gt;
*** Lausanne&lt;br /&gt;
*** Geneva&lt;br /&gt;
** Methods | Methods&lt;br /&gt;
** People | People&lt;br /&gt;
** Publications | Publications&lt;br /&gt;
** Contact | Contact&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Contact</id>
		<title>Contact</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Contact"/>
				<updated>2013-03-16T00:26:04Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
'''Community Prevention Unit, Institute of Social and Preventive Medicine (IUMSP)'''&lt;br /&gt;
&lt;br /&gt;
10, route de la Corniche&lt;br /&gt;
&lt;br /&gt;
1010 Lausanne&lt;br /&gt;
Switzerland&lt;br /&gt;
&lt;br /&gt;
Tel : ++41 21 314 72 72; Fax: ++41 21 314 73 73&lt;br /&gt;
&lt;br /&gt;
E-mail Ms Filomena Jacquier: Filomena.Jacquier@chuv.ch&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/People</id>
		<title>People</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/People"/>
				<updated>2013-03-14T22:27:50Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Lausanne'''&lt;br /&gt;
&lt;br /&gt;
Prof [[Murielle Bochud]], MD PhD, principal investigator&lt;br /&gt;
&lt;br /&gt;
Prof Michel Burnier, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof [[Fred Paccaud]], MD, investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Menno Pruijm]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Marie-Eve Müller, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Heba Al-Alwan, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Pierre Monney, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Sandrine Estoppey, MSc, coordinator&lt;br /&gt;
&lt;br /&gt;
Mrs Sylvie Tremblay, research nurse&lt;br /&gt;
&lt;br /&gt;
Mrs Güler Gök-Sogut, medical assistant&lt;br /&gt;
&lt;br /&gt;
Mrs [[Jacquier Filomena]], administrative assistant&lt;br /&gt;
&lt;br /&gt;
Mrs Renata Testaz, administrator&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Geneva'''&lt;br /&gt;
&lt;br /&gt;
Prof Pierre-Yves Martin, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof [[Antoinette Pechere | Antoinette Péchère-Bertschi]], MD, investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Belen Ponte]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Idris Guessous, MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr [[Georg Ehret]] MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Yassine Bouatou, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Stéphane Reverdin, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Marie-Odile Lévi, research nurse&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Bern'''&lt;br /&gt;
&lt;br /&gt;
Prof Bruno Vogt, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Markus Mohaupt, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Felix Frey, MD (retired), investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Daniel Ackermann]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Nasser Dahyat, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Ulla Schüpbach, research nurse&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Zurich'''&lt;br /&gt;
&lt;br /&gt;
Prof [[Olivier Devuyst]], MD&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Welcome_to_the_SKIPOGH_study!</id>
		<title>Welcome to the SKIPOGH study!</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Welcome_to_the_SKIPOGH_study!"/>
				<updated>2013-03-09T23:42:19Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:#ffff66&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&amp;lt;br /&amp;gt;&lt;br /&gt;
SKIPOGH stands for the Swiss Kidney Project on Genes in Hypertension; its aim is to explore the role of genetics and the environment (nutrition, physical activity, and way of life) on blood pressure regulation and kidney function. SKIPOGH will also increase the knowledge on the health status of inhabitants from Lausanne, Geneva and Bern, and allow scientists to assess to what degree parameters such as blood pressure, kidney size and function, body weight, and metabolism are inherited. The SKIPOGH study is embedded in the EPOGH study (European Project on Genes in Hypertension), an international cohort exploring the genetic determinants of blood pressure (BP) in the general population, and follows largely the same standardized protocol.&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Skipogh_logo.png]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- =============== PIED DE PAGE =============== --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin:0 0 0 0; background:none; width:100%; margin-top:12px; background:transparent;&amp;quot;&lt;br /&gt;
{| width=&amp;quot;100%&amp;quot; style=&amp;quot; padding:5px; margin-top:0px; margin-bottom:0px; background:transparent;&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| align=center |[[File:Chuv.gif|60px|top]]   [[File:Logo HUG.gif|120px|top]]   [[File:Insellogo-sw.jpg|120px|top]]   [[File:Unizürich-transparent-web.png|120px|top]]&lt;br /&gt;
&amp;lt;br /&amp;gt; &amp;lt;small&amp;gt;SKIPOGH investigators 2013&amp;lt;/small&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Welcome_to_the_SKIPOGH_study!</id>
		<title>Welcome to the SKIPOGH study!</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Welcome_to_the_SKIPOGH_study!"/>
				<updated>2013-03-09T23:41:55Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:#ffff66&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&amp;lt;br /&amp;gt;&lt;br /&gt;
SSKIPOGH stands for the Swiss Kidney Project on Genes in Hypertension; its aim is to explore the role of genetics and the environment (nutrition, physical activity, and way of life) on blood pressure regulation and kidney function. SKIPOGH will also increase the knowledge on the health status of inhabitants from Lausanne, Geneva and Bern, and allow scientists to assess to what degree parameters such as blood pressure, kidney size and function, body weight, and metabolism are inherited. The SKIPOGH study is embedded in the EPOGH study (European Project on Genes in Hypertension), an international cohort exploring the genetic determinants of blood pressure (BP) in the general population, and follows largely the same standardized protocol.&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Skipogh_logo.png]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- =============== PIED DE PAGE =============== --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin:0 0 0 0; background:none; width:100%; margin-top:12px; background:transparent;&amp;quot;&lt;br /&gt;
{| width=&amp;quot;100%&amp;quot; style=&amp;quot; padding:5px; margin-top:0px; margin-bottom:0px; background:transparent;&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| align=center |[[File:Chuv.gif|60px|top]]   [[File:Logo HUG.gif|120px|top]]   [[File:Insellogo-sw.jpg|120px|top]]   [[File:Unizürich-transparent-web.png|120px|top]]&lt;br /&gt;
&amp;lt;br /&amp;gt; &amp;lt;small&amp;gt;SKIPOGH investigators 2013&amp;lt;/small&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/MediaWiki:Sidebar</id>
		<title>MediaWiki:Sidebar</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/MediaWiki:Sidebar"/>
				<updated>2013-03-09T23:18:41Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;#wiki_navigate {font-size:20px;}&lt;br /&gt;
#wiki_navigate a {color: green;}&lt;br /&gt;
&lt;br /&gt;
* navigation&lt;br /&gt;
** News | News&lt;br /&gt;
** Centers | Centers&lt;br /&gt;
*** Lausanne&lt;br /&gt;
*** Geneva&lt;br /&gt;
** Methods | Methods&lt;br /&gt;
** People | People&lt;br /&gt;
** Publications | Publications&lt;br /&gt;
** Contact | Contact&lt;br /&gt;
* language&lt;br /&gt;
** English | English&lt;br /&gt;
** French | French&lt;br /&gt;
** German | German&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/MediaWiki:Sidebar</id>
		<title>MediaWiki:Sidebar</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/MediaWiki:Sidebar"/>
				<updated>2013-03-09T23:18:06Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;#wiki_navigate {font-size:20px;}&lt;br /&gt;
#wiki_navigate a {color: green;}&lt;br /&gt;
&lt;br /&gt;
* navigation&lt;br /&gt;
** News | News&lt;br /&gt;
** Centers | Centers&lt;br /&gt;
*** Lausanne&lt;br /&gt;
*** Geneva&lt;br /&gt;
** Methods | Methods&lt;br /&gt;
** People | People&lt;br /&gt;
** Publications | Publications&lt;br /&gt;
** Contact | Contact&lt;br /&gt;
* languages&lt;br /&gt;
** English | English&lt;br /&gt;
** French | French&lt;br /&gt;
** German | German&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/MediaWiki:Sidebar</id>
		<title>MediaWiki:Sidebar</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/MediaWiki:Sidebar"/>
				<updated>2013-03-09T23:10:18Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;#wiki_navigate {font-size:20px;}&lt;br /&gt;
#wiki_navigate a {color: green;}&lt;br /&gt;
&lt;br /&gt;
* navigation&lt;br /&gt;
** News | News&lt;br /&gt;
** Centers | Centers&lt;br /&gt;
*** Lausanne&lt;br /&gt;
*** Geneva&lt;br /&gt;
** Methods | Methods&lt;br /&gt;
** People | People&lt;br /&gt;
** Publications | Publications&lt;br /&gt;
** Contact | Contact&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/MediaWiki:Sidebar</id>
		<title>MediaWiki:Sidebar</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/MediaWiki:Sidebar"/>
				<updated>2013-03-09T23:10:00Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;#wiki_navigate {font-size:20px;}&lt;br /&gt;
#wiki_navigate a {color: green;}&lt;br /&gt;
&lt;br /&gt;
* navigation&lt;br /&gt;
** News&lt;br /&gt;
** Centers | Centers&lt;br /&gt;
*** Lausanne&lt;br /&gt;
*** Geneva&lt;br /&gt;
** Methods | Methods&lt;br /&gt;
** People | People&lt;br /&gt;
** Publications | Publications&lt;br /&gt;
** Contact | Contact&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Welcome_to_the_SKIPOGH_study!</id>
		<title>Welcome to the SKIPOGH study!</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Welcome_to_the_SKIPOGH_study!"/>
				<updated>2013-03-09T23:04:42Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:#ffff66&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&amp;lt;br /&amp;gt;&lt;br /&gt;
SKIPOGH stands for the Swiss Kidney Project on Genes in Hypertension; its aim is to explore the role of genetics and the environment (nutrition, physical activity, and way of life) on blood pressure regulation and kidney function. SKIPOGH will also increase the knowledge on the health status of inhabitants from Lausanne, Geneva and Bern, and allow scientists to assess to what degree parameters such as blood pressure, kidney size and function, body weight, and metabolism are inherited. The SKIPOGH study is embedded in the EPOGH study (European Project on Genes in Hypertension), an international cohort exploring the genetic determinants of blood pressure (BP) in the general population, and follows largely the same standardized protocol.&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Skipogh_logo.png]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- =============== PIED DE PAGE =============== --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin:0 0 0 0; background:none; width:100%; margin-top:12px; background:transparent;&amp;quot;&lt;br /&gt;
{| width=&amp;quot;100%&amp;quot; style=&amp;quot; padding:5px; margin-top:0px; margin-bottom:0px; background:transparent;&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| align=center |[[File:Chuv.gif|60px|top]]   [[File:Logo HUG.gif|120px|top]]   [[File:Insellogo-sw.jpg|120px|top]]   [[File:Unizürich-transparent-web.png|120px|top]]&lt;br /&gt;
&amp;lt;br /&amp;gt; &amp;lt;small&amp;gt;SKIPOGH investigators 2013&amp;lt;/small&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Welcome_to_the_SKIPOGH_study!</id>
		<title>Welcome to the SKIPOGH study!</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Welcome_to_the_SKIPOGH_study!"/>
				<updated>2013-03-09T23:03:51Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: Created page with &amp;quot;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt; {| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot; | style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top;...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:#ffff66&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&lt;br /&gt;
SKIPOGH stands for the Swiss Kidney Project on Genes in Hypertension; its aim is to explore the role of genetics and the environment (nutrition, physical activity, and way of life) on blood pressure regulation and kidney function. SKIPOGH will also increase the knowledge on the health status of inhabitants from Lausanne, Geneva and Bern, and allow scientists to assess to what degree parameters such as blood pressure, kidney size and function, body weight, and metabolism are inherited. The SKIPOGH study is embedded in the EPOGH study (European Project on Genes in Hypertension), an international cohort exploring the genetic determinants of blood pressure (BP) in the general population, and follows largely the same standardized protocol.&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Skipogh_logo.png]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- =============== PIED DE PAGE =============== --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin:0 0 0 0; background:none; width:100%; margin-top:12px; background:transparent;&amp;quot;&lt;br /&gt;
{| width=&amp;quot;100%&amp;quot; style=&amp;quot; padding:5px; margin-top:0px; margin-bottom:0px; background:transparent;&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| align=center |[[File:Chuv.gif|60px|top]]   [[File:Logo HUG.gif|120px|top]]   [[File:Insellogo-sw.jpg|120px|top]]   [[File:Unizürich-transparent-web.png|120px|top]]&lt;br /&gt;
&amp;lt;br /&amp;gt; &amp;lt;small&amp;gt;SKIPOGH investigators 2013&amp;lt;/small&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/MediaWiki:Mainpage</id>
		<title>MediaWiki:Mainpage</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/MediaWiki:Mainpage"/>
				<updated>2013-03-09T23:03:20Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Welcome to the SKIPOGH study!&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Centers</id>
		<title>Centers</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Centers"/>
				<updated>2013-03-09T19:03:08Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;More than 7000 persons have participated to EPOGH in Europe. EPOGH has resulted in over 100 scientific publications in the field of hypertension (high blood pressure) and genetics. It has substantially participated to the breakthrough established in 2009 in high blood pressure research, identifying 13 loci (regions of the chromosome) that are associated with high blood pressure. Of note, one of the SKIPOGH-investigators was first author of this paper.&lt;br /&gt;
&lt;br /&gt;
The goal of SKIPOGH is to screen 1200 Swiss inhabitants, from approximately 400 families. A simple, non stratified sample of subjects has been drawn from lists of inhabitants provided by the population registers of the three cities. A letter inviting the addressee to participate is sent, and subjects are contacted within 14 days by one of the staff members. The following inclusion criteria are applied: (a) written informed consent; (b) minimum age 18 years; (c) willingness to take part in the examination and donate blood sample; (d) Caucasian origin, defined as having both parents and grandparents born in a restricted list of countries (available from the authors) (e) at least one, and preferably three, first degree family members also willing to participate. The family members are contacted in a similar way, and an appointment for a study visit is set individually with each family member. The SKIPOGH study was approved by the Institutional Ethics Committee of the Universities of Bern, Geneva and Lausanne. SKIPOGH has started recruitment in January 2010. In July 2011, a total number of 600 persons was reached. Recruitment shall continue until April 2013.&lt;br /&gt;
&lt;br /&gt;
The SKIPOGH study has 4 field centers ('''Lausanne, Geneva, Bern, Zurich''') and the data coordinating center in Lausanne.&lt;br /&gt;
&lt;br /&gt;
The [http://www.staessen.net European Coordinating Center] is in Leuven under the direction of Prof. Staessen.&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Methods</id>
		<title>Methods</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Methods"/>
				<updated>2013-03-09T19:02:42Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Participants come to the study center on weekdays, in general between 8am-9am after an overnight fast. They are allowed to drink water and to take their usual medication. They are welcomed by one of the medical assistants or study nurses, and the study procedures are explained. Total duration of the ‘check-up’ is 2h-2h30. First of all, the blood pressure is measured on both arms as shown in figure 1.  For blood pressure&lt;br /&gt;
measurement, the A&amp;amp;D UM-101 (A&amp;amp;D Company, Ltd., Toshima Ku, Tokyo, Japan) is used, a non-mercury manual auscultatory sphygmomanometer. This device has the same precision as the classical mercury sphygmomanometer, and has replaced the latter for ecological reasons.&lt;br /&gt;
&lt;br /&gt;
[[File:bp.jpg |200px|caption]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Body weight and size are measured, followed by the abdominal circumference. Of note, measurement of these parameters are used-among others- to calculate the so called ‘Body Mass Index (formula= body weight (kg)/ (length in meters). The BMI allows the classification into different categories of weight:  &amp;lt;20 underweight, 20-25 normal, 25-30 overweight, and ≥30 obese.&lt;br /&gt;
&lt;br /&gt;
The hand grip strength of the right and left hand is measured three times with the ‘Baseline Hydraulic Hand Dynamometer®’ (see figure) with subjects in a standing position. Subjects hold the dynamometer at thigh level and are encouraged to exert the strongest possible force, each time for several seconds. Hand grip strength offers information on muscle mass and nutritional status. HSG is of special interest in older individuals (&amp;gt;65 years), since some studies have shown that reduced HSG is associated with an increased risk of mortality.&lt;br /&gt;
&lt;br /&gt;
Bioelectrical –impedance analysis (BIA) is a non-invasive technique which allows assessment of body composition (fat mass, muscle mass, hydration level) in a few seconds. Two electrodes are attached to the right hand and the right foot, and the bio-impedance (Ω) to a very weak electric current between the electrodes is measured, which allows on its term body composition assessment.  Moreover, basal metabolic rate and the estimated daily caloric need are calculated using an incorporated algorithm.&lt;br /&gt;
&lt;br /&gt;
[[File:electr.jpg|200px]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
An electrocardiogram (ECG) is obtained with the SDS-104 device from Schiller. ECG measures the electric activity of the heart, and provides essential information on heart functioning, such as heart rate, eventual ischemia (lack of oxygen) and/or hypertrophy (muscular over-development of the heart). The ECG is part of the medical report that is given to all participants the day after during the home visit, and a copy of the medical report is sent to the treating physician, if wished by the participant.&lt;br /&gt;
&lt;br /&gt;
Venous blood sampling is performed. Approximately 70 ml of blood is drawn from a forearm vein, which corresponds to about the same volume as half a cup of coffee. Blood sugar level, cholesterol profile, electrolytes, whole blood count (including red and white blood cells and platelets) and liver-and kidney function tests are dosed in the blood on the same day, and results are mentioned in the medical report. More specialized tests such as dosage of hormones implemented in blood pressure regulation and renal sodium handling are performed in a later stage.&lt;br /&gt;
&lt;br /&gt;
In order to study the elastic properties of the arteries in a non-invasive way, a so called pulse wave analysis is performed, using a Sphygmocor device (AtCor Medical Pty. Ltd., West Ryde, Australia). Briefly, a small tonometer measures elasticity of the right carotid, radial and femoral artery, by applying a little bit of pressure at the corresponding anatomical regions. Total duration of this exam is 15 minutes. The elasticity of the artery influences the pulse wave velocity (PWV), which on his term correlates with the global degree of atherosclerosis (‘calcification’ and formation of cholesterol deposits in of the artery wall) of the participant. Atherosclerosis is the main culprit of arterial narrowing and eventually occlusion, which leads to heart infarcts or cerebral infarcts, depending of which arteries are affected.&lt;br /&gt;
&lt;br /&gt;
[[File:sphigmo_rad.jpg|200px]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Besides, the Sphygmocor device provides an estimation of the blood pressure in the aorta (‘central blood pressure’). The central blood pressure is a more precise predictor of future cardiovascular events than the blood pressure measured at the arm, and experts believe that it will become an essential tool to take therapeutic decisions regarding blood pressure treatment in the future.&lt;br /&gt;
&lt;br /&gt;
Abdominal ultrasound is performed in every participant. This is one of the reasons that participants should come after an overnight fast, since visibility is reduced after meals. The ultrasound exam is painless, free of irradiation, and without known side effects. Of note, it is the only radiological exam than can be safely performed throughout pregnancy. In SKIPOGH, the ultrasound focuses on the kidneys, since kidneys are key regulators of blood pressure. Kidney size, volume, and vascular properties are therefore measured in detail. Other organs such as the gallbladder, liver and prostate are briefly visualized, and an estimation of the aortic diameter assessed. In case of the detection of an anomaly (cyst, kidney stone, other), the participant as well as his/her treating physician is informed without delay.&lt;br /&gt;
&lt;br /&gt;
[[File:renalUS.jpg|200px]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
After the abdominal ultrasound, a Diasys® device is installed on the non-dominant arm, which measures every 20-30 minutes the arterial blood pressure. The participant leaves the clinic with the Diasys® device, and will collect all urine produced the same day and night in two separate urine containers. Finally, a questionnaire is filled in at home by the participant (duration: 30 minutes). The questionnaire includes question s on previous medical history, medication intake, professional life, and life habits (alimentation, physical activity).&lt;br /&gt;
&lt;br /&gt;
The following day, a home visit is performed by a study nurse. Home blood pressure is measured five times, the questionnaire is revised by the research nurse, the Diasys® device removed and urinary containers collected. The research nurse will also hand over the medical report to the participant, mentioning that in case of questions, the participant should not hesitate to contact the responsible physician of the study center.&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Methods</id>
		<title>Methods</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Methods"/>
				<updated>2013-03-09T19:00:55Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Participants come to the study center on weekdays, in general between 8am-9am after an overnight fast. They are allowed to drink water and to take their usual medication. They are welcomed by one of the medical assistants or study nurses, and the study procedures are explained. Total duration of the ‘check-up’ is 2h-2h30. First of all, the blood pressure is measured on both arms as shown in figure 1.  For blood pressure&lt;br /&gt;
measurement, the A&amp;amp;D UM-101 (A&amp;amp;D Company, Ltd., Toshima Ku, Tokyo, Japan) is used, a non-mercury manual auscultatory sphygmomanometer. This device has the same precision as the classical mercury sphygmomanometer, and has replaced the latter for ecological reasons.&lt;br /&gt;
&lt;br /&gt;
[[File:bp.jpg |200px|caption]]&lt;br /&gt;
&lt;br /&gt;
Body weight and size are measured, followed by the abdominal circumference. Of note, measurement of these parameters are used-among others- to calculate the so called ‘Body Mass Index (formula= body weight (kg)/ (length in meters). The BMI allows the classification into different categories of weight:  &amp;lt;20 underweight, 20-25 normal, 25-30 overweight, and ≥30 obese.&lt;br /&gt;
&lt;br /&gt;
The hand grip strength of the right and left hand is measured three times with the ‘Baseline Hydraulic Hand Dynamometer®’ (see figure) with subjects in a standing position. Subjects hold the dynamometer at thigh level and are encouraged to exert the strongest possible force, each time for several seconds. Hand grip strength offers information on muscle mass and nutritional status. HSG is of special interest in older individuals (&amp;gt;65 years), since some studies have shown that reduced HSG is associated with an increased risk of mortality.&lt;br /&gt;
&lt;br /&gt;
Bioelectrical –impedance analysis (BIA) is a non-invasive technique which allows assessment of body composition (fat mass, muscle mass, hydration level) in a few seconds. Two electrodes are attached to the right hand and the right foot, and the bio-impedance (Ω) to a very weak electric current between the electrodes is measured, which allows on its term body composition assessment.  Moreover, basal metabolic rate and the estimated daily caloric need are calculated using an incorporated algorithm.&lt;br /&gt;
[[File:electr.jpg|200px]]&lt;br /&gt;
&lt;br /&gt;
An electrocardiogram (ECG) is obtained with the SDS-104 device from Schiller. ECG measures the electric activity of the heart, and provides essential information on heart functioning, such as heart rate, eventual ischemia (lack of oxygen) and/or hypertrophy (muscular over-development of the heart). The ECG is part of the medical report that is given to all participants the day after during the home visit, and a copy of the medical report is sent to the treating physician, if wished by the participant.&lt;br /&gt;
&lt;br /&gt;
Venous blood sampling is performed. Approximately 70 ml of blood is drawn from a forearm vein, which corresponds to about the same volume as half a cup of coffee. Blood sugar level, cholesterol profile, electrolytes, whole blood count (including red and white blood cells and platelets) and liver-and kidney function tests are dosed in the blood on the same day, and results are mentioned in the medical report. More specialized tests such as dosage of hormones implemented in blood pressure regulation and renal sodium handling are performed in a later stage.&lt;br /&gt;
&lt;br /&gt;
In order to study the elastic properties of the arteries in a non-invasive way, a so called pulse wave analysis is performed, using a Sphygmocor device (AtCor Medical Pty. Ltd., West Ryde, Australia). Briefly, a small tonometer measures elasticity of the right carotid, radial and femoral artery, by applying a little bit of pressure at the corresponding anatomical regions. Total duration of this exam is 15 minutes. The elasticity of the artery influences the pulse wave velocity (PWV), which on his term correlates with the global degree of atherosclerosis (‘calcification’ and formation of cholesterol deposits in of the artery wall) of the participant. Atherosclerosis is the main culprit of arterial narrowing and eventually occlusion, which leads to heart infarcts or cerebral infarcts, depending of which arteries are affected.&lt;br /&gt;
[[File:sphigmo_rad.jpg|200px]]&lt;br /&gt;
&lt;br /&gt;
Besides, the Sphygmocor device provides an estimation of the blood pressure in the aorta (‘central blood pressure’). The central blood pressure is a more precise predictor of future cardiovascular events than the blood pressure measured at the arm, and experts believe that it will become an essential tool to take therapeutic decisions regarding blood pressure treatment in the future.&lt;br /&gt;
&lt;br /&gt;
Abdominal ultrasound is performed in every participant. This is one of the reasons that participants should come after an overnight fast, since visibility is reduced after meals. The ultrasound exam is painless, free of irradiation, and without known side effects. Of note, it is the only radiological exam than can be safely performed throughout pregnancy. In SKIPOGH, the ultrasound focuses on the kidneys, since kidneys are key regulators of blood pressure. Kidney size, volume, and vascular properties are therefore measured in detail. Other organs such as the gallbladder, liver and prostate are briefly visualized, and an estimation of the aortic diameter assessed. In case of the detection of an anomaly (cyst, kidney stone, other), the participant as well as his/her treating physician is informed without delay.&lt;br /&gt;
[[File:renalUS.jpg|200px]]&lt;br /&gt;
After the abdominal ultrasound, a Diasys® device is installed on the non-dominant arm, which measures every 20-30 minutes the arterial blood pressure. The participant leaves the clinic with the Diasys® device, and will collect all urine produced the same day and night in two separate urine containers. Finally, a questionnaire is filled in at home by the participant (duration: 30 minutes). The questionnaire includes question s on previous medical history, medication intake, professional life, and life habits (alimentation, physical activity).&lt;br /&gt;
&lt;br /&gt;
The following day, a home visit is performed by a study nurse. Home blood pressure is measured five times, the questionnaire is revised by the research nurse, the Diasys® device removed and urinary containers collected. The research nurse will also hand over the medical report to the participant, mentioning that in case of questions, the participant should not hesitate to contact the responsible physician of the study center.&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Methods</id>
		<title>Methods</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Methods"/>
				<updated>2013-03-09T19:00:16Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Participants come to the study center on weekdays, in general between 8am-9am after an overnight fast. They are allowed to drink water and to take their usual medication. They are welcomed by one of the medical assistants or study nurses, and the study procedures are explained. Total duration of the ‘check-up’ is 2h-2h30. First of all, the blood pressure is measured on both arms as shown in figure 1.  For blood pressure&lt;br /&gt;
measurement, the A&amp;amp;D UM-101 (A&amp;amp;D Company, Ltd., Toshima Ku, Tokyo, Japan) is used, a non-mercury manual auscultatory sphygmomanometer. This device has the same precision as the classical mercury sphygmomanometer, and has replaced the latter for ecological reasons.&lt;br /&gt;
[[File:bp.jpg |300px|caption]]&lt;br /&gt;
&lt;br /&gt;
Body weight and size are measured, followed by the abdominal circumference. Of note, measurement of these parameters are used-among others- to calculate the so called ‘Body Mass Index (formula= body weight (kg)/ (length in meters). The BMI allows the classification into different categories of weight:  &amp;lt;20 underweight, 20-25 normal, 25-30 overweight, and ≥30 obese.&lt;br /&gt;
&lt;br /&gt;
The hand grip strength of the right and left hand is measured three times with the ‘Baseline Hydraulic Hand Dynamometer®’ (see figure) with subjects in a standing position. Subjects hold the dynamometer at thigh level and are encouraged to exert the strongest possible force, each time for several seconds. Hand grip strength offers information on muscle mass and nutritional status. HSG is of special interest in older individuals (&amp;gt;65 years), since some studies have shown that reduced HSG is associated with an increased risk of mortality.&lt;br /&gt;
&lt;br /&gt;
Bioelectrical –impedance analysis (BIA) is a non-invasive technique which allows assessment of body composition (fat mass, muscle mass, hydration level) in a few seconds. Two electrodes are attached to the right hand and the right foot, and the bio-impedance (Ω) to a very weak electric current between the electrodes is measured, which allows on its term body composition assessment.  Moreover, basal metabolic rate and the estimated daily caloric need are calculated using an incorporated algorithm.&lt;br /&gt;
[[File:electr.jpg|300px]]&lt;br /&gt;
&lt;br /&gt;
An electrocardiogram (ECG) is obtained with the SDS-104 device from Schiller. ECG measures the electric activity of the heart, and provides essential information on heart functioning, such as heart rate, eventual ischemia (lack of oxygen) and/or hypertrophy (muscular over-development of the heart). The ECG is part of the medical report that is given to all participants the day after during the home visit, and a copy of the medical report is sent to the treating physician, if wished by the participant.&lt;br /&gt;
&lt;br /&gt;
Venous blood sampling is performed. Approximately 70 ml of blood is drawn from a forearm vein, which corresponds to about the same volume as half a cup of coffee. Blood sugar level, cholesterol profile, electrolytes, whole blood count (including red and white blood cells and platelets) and liver-and kidney function tests are dosed in the blood on the same day, and results are mentioned in the medical report. More specialized tests such as dosage of hormones implemented in blood pressure regulation and renal sodium handling are performed in a later stage.&lt;br /&gt;
&lt;br /&gt;
In order to study the elastic properties of the arteries in a non-invasive way, a so called pulse wave analysis is performed, using a Sphygmocor device (AtCor Medical Pty. Ltd., West Ryde, Australia). Briefly, a small tonometer measures elasticity of the right carotid, radial and femoral artery, by applying a little bit of pressure at the corresponding anatomical regions. Total duration of this exam is 15 minutes. The elasticity of the artery influences the pulse wave velocity (PWV), which on his term correlates with the global degree of atherosclerosis (‘calcification’ and formation of cholesterol deposits in of the artery wall) of the participant. Atherosclerosis is the main culprit of arterial narrowing and eventually occlusion, which leads to heart infarcts or cerebral infarcts, depending of which arteries are affected.&lt;br /&gt;
[[File:sphigmo_rad.jpg|300px]]&lt;br /&gt;
&lt;br /&gt;
Besides, the Sphygmocor device provides an estimation of the blood pressure in the aorta (‘central blood pressure’). The central blood pressure is a more precise predictor of future cardiovascular events than the blood pressure measured at the arm, and experts believe that it will become an essential tool to take therapeutic decisions regarding blood pressure treatment in the future.&lt;br /&gt;
&lt;br /&gt;
Abdominal ultrasound is performed in every participant. This is one of the reasons that participants should come after an overnight fast, since visibility is reduced after meals. The ultrasound exam is painless, free of irradiation, and without known side effects. Of note, it is the only radiological exam than can be safely performed throughout pregnancy. In SKIPOGH, the ultrasound focuses on the kidneys, since kidneys are key regulators of blood pressure. Kidney size, volume, and vascular properties are therefore measured in detail. Other organs such as the gallbladder, liver and prostate are briefly visualized, and an estimation of the aortic diameter assessed. In case of the detection of an anomaly (cyst, kidney stone, other), the participant as well as his/her treating physician is informed without delay.&lt;br /&gt;
[[File:renalUS.jpg|300px]]&lt;br /&gt;
After the abdominal ultrasound, a Diasys® device is installed on the non-dominant arm, which measures every 20-30 minutes the arterial blood pressure. The participant leaves the clinic with the Diasys® device, and will collect all urine produced the same day and night in two separate urine containers. Finally, a questionnaire is filled in at home by the participant (duration: 30 minutes). The questionnaire includes question s on previous medical history, medication intake, professional life, and life habits (alimentation, physical activity).&lt;br /&gt;
&lt;br /&gt;
The following day, a home visit is performed by a study nurse. Home blood pressure is measured five times, the questionnaire is revised by the research nurse, the Diasys® device removed and urinary containers collected. The research nurse will also hand over the medical report to the participant, mentioning that in case of questions, the participant should not hesitate to contact the responsible physician of the study center.&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Methods</id>
		<title>Methods</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Methods"/>
				<updated>2013-03-09T18:59:14Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Participants come to the study center on weekdays, in general between 8am-9am after an overnight fast. They are allowed to drink water and to take their usual medication. They are welcomed by one of the medical assistants or study nurses, and the study procedures are explained. Total duration of the ‘check-up’ is 2h-2h30. First of all, the blood pressure is measured on both arms as shown in figure 1.  For blood pressure&lt;br /&gt;
measurement, the A&amp;amp;D UM-101 (A&amp;amp;D Company, Ltd., Toshima Ku, Tokyo, Japan) is used, a non-mercury manual auscultatory sphygmomanometer. [[File:bp.jpg |300px|caption]]This device has the same precision as the classical mercury sphygmomanometer, and has replaced the latter for ecological reasons.&lt;br /&gt;
&lt;br /&gt;
Body weight and size are measured, followed by the abdominal circumference. Of note, measurement of these parameters are used-among others- to calculate the so called ‘Body Mass Index (formula= body weight (kg)/ (length in meters). The BMI allows the classification into different categories of weight:  &amp;lt;20 underweight, 20-25 normal, 25-30 overweight, and ≥30 obese.&lt;br /&gt;
&lt;br /&gt;
The hand grip strength of the right and left hand is measured three times with the ‘Baseline Hydraulic Hand Dynamometer®’ (see figure) with subjects in a standing position. Subjects hold the dynamometer at thigh level and are encouraged to exert the strongest possible force, each time for several seconds. Hand grip strength offers information on muscle mass and nutritional status. HSG is of special interest in older individuals (&amp;gt;65 years), since some studies have shown that reduced HSG is associated with an increased risk of mortality.&lt;br /&gt;
&lt;br /&gt;
Bioelectrical –impedance analysis (BIA) is a non-invasive technique which allows assessment of body composition (fat mass, muscle mass, hydration level) in a few seconds. [[File:electr.jpg|300px]]Two electrodes are attached to the right hand and the right foot, and the bio-impedance (Ω) to a very weak electric current between the electrodes is measured, which allows on its term body composition assessment.  Moreover, basal metabolic rate and the estimated daily caloric need are calculated using an incorporated algorithm.&lt;br /&gt;
&lt;br /&gt;
An electrocardiogram (ECG) is obtained with the SDS-104 device from Schiller. ECG measures the electric activity of the heart, and provides essential information on heart functioning, such as heart rate, eventual ischemia (lack of oxygen) and/or hypertrophy (muscular over-development of the heart). The ECG is part of the medical report that is given to all participants the day after during the home visit, and a copy of the medical report is sent to the treating physician, if wished by the participant.&lt;br /&gt;
&lt;br /&gt;
Venous blood sampling is performed. Approximately 70 ml of blood is drawn from a forearm vein, which corresponds to about the same volume as half a cup of coffee. Blood sugar level, cholesterol profile, electrolytes, whole blood count (including red and white blood cells and platelets) and liver-and kidney function tests are dosed in the blood on the same day, and results are mentioned in the medical report. More specialized tests such as dosage of hormones implemented in blood pressure regulation and renal sodium handling are performed in a later stage.&lt;br /&gt;
&lt;br /&gt;
In order to study the elastic properties of the arteries in a non-invasive way, a so called pulse wave analysis is performed, using a Sphygmocor device (AtCor Medical Pty. Ltd., West Ryde, Australia). [[File:sphigmo_carot.jpg|300px]]Briefly, a small tonometer measures elasticity of the right carotid, radial and femoral artery, by applying a little bit of pressure at the corresponding anatomical regions. Total duration of this exam is 15 minutes. The elasticity of the artery influences the pulse wave velocity (PWV), which on his term correlates with the global degree of atherosclerosis (‘calcification’ and formation of cholesterol deposits in of the artery wall) of the participant. Atherosclerosis is the main culprit of arterial narrowing and eventually occlusion, which leads to heart infarcts or cerebral infarcts, depending of which arteries are affected.[[File:sphigmo_rad.jpg|300px]]&lt;br /&gt;
&lt;br /&gt;
Besides, the Sphygmocor device provides an estimation of the blood pressure in the aorta (‘central blood pressure’). The central blood pressure is a more precise predictor of future cardiovascular events than the blood pressure measured at the arm, and experts believe that it will become an essential tool to take therapeutic decisions regarding blood pressure treatment in the future.&lt;br /&gt;
&lt;br /&gt;
Abdominal ultrasound is performed in every participant[[File:renalUS.jpg|300px]]. This is one of the reasons that participants should come after an overnight fast, since visibility is reduced after meals. The ultrasound exam is painless, free of irradiation, and without known side effects. Of note, it is the only radiological exam than can be safely performed throughout pregnancy. In SKIPOGH, the ultrasound focuses on the kidneys, since kidneys are key regulators of blood pressure. Kidney size, volume, and vascular properties are therefore measured in detail. Other organs such as the gallbladder, liver and prostate are briefly visualized, and an estimation of the aortic diameter assessed. In case of the detection of an anomaly (cyst, kidney stone, other), the participant as well as his/her treating physician is informed without delay.&lt;br /&gt;
After the abdominal ultrasound, a Diasys® device is installed on the non-dominant arm, which measures every 20-30 minutes the arterial blood pressure. The participant leaves the clinic with the Diasys® device, and will collect all urine produced the same day and night in two separate urine containers. Finally, a questionnaire is filled in at home by the participant (duration: 30 minutes). The questionnaire includes question s on previous medical history, medication intake, professional life, and life habits (alimentation, physical activity).&lt;br /&gt;
&lt;br /&gt;
The following day, a home visit is performed by a study nurse. Home blood pressure is measured five times, the questionnaire is revised by the research nurse, the Diasys® device removed and urinary containers collected. The research nurse will also hand over the medical report to the participant, mentioning that in case of questions, the participant should not hesitate to contact the responsible physician of the study center.&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Methods</id>
		<title>Methods</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Methods"/>
				<updated>2013-03-09T18:57:20Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Participants come to the study center on weekdays, in general between 8am-9am after an overnight fast. They are allowed to drink water and to take their usual medication. They are welcomed by one of the medical assistants or study nurses, and the study procedures are explained. Total duration of the ‘check-up’ is 2h-2h30. First of all, the blood pressure is measured on both arms as shown in figure 1.  For blood pressure&lt;br /&gt;
measurement, the A&amp;amp;D UM-101 (A&amp;amp;D Company, Ltd., Toshima Ku, Tokyo, Japan) is used, a non-mercury manual auscultatory sphygmomanometer. [[File:bp.jpg |300px]]This device has the same precision as the classical mercury sphygmomanometer, and has replaced the latter for ecological reasons.&lt;br /&gt;
&lt;br /&gt;
Body weight and size are measured, followed by the abdominal circumference. Of note, measurement of these parameters are used-among others- to calculate the so called ‘Body Mass Index (formula= body weight (kg)/ (length in meters). The BMI allows the classification into different categories of weight:  &amp;lt;20 underweight, 20-25 normal, 25-30 overweight, and ≥30 obese.&lt;br /&gt;
&lt;br /&gt;
The hand grip strength of the right and left hand is measured three times with the ‘Baseline Hydraulic Hand Dynamometer®’ (see figure) with subjects in a standing position. Subjects hold the dynamometer at thigh level and are encouraged to exert the strongest possible force, each time for several seconds. Hand grip strength offers information on muscle mass and nutritional status. HSG is of special interest in older individuals (&amp;gt;65 years), since some studies have shown that reduced HSG is associated with an increased risk of mortality.&lt;br /&gt;
&lt;br /&gt;
Bioelectrical –impedance analysis (BIA) is a non-invasive technique which allows assessment of body composition (fat mass, muscle mass, hydration level) in a few seconds. [[File:electr.jpg|300px]]Two electrodes are attached to the right hand and the right foot, and the bio-impedance (Ω) to a very weak electric current between the electrodes is measured, which allows on its term body composition assessment.  Moreover, basal metabolic rate and the estimated daily caloric need are calculated using an incorporated algorithm.&lt;br /&gt;
&lt;br /&gt;
An electrocardiogram (ECG) is obtained with the SDS-104 device from Schiller. ECG measures the electric activity of the heart, and provides essential information on heart functioning, such as heart rate, eventual ischemia (lack of oxygen) and/or hypertrophy (muscular over-development of the heart). The ECG is part of the medical report that is given to all participants the day after during the home visit, and a copy of the medical report is sent to the treating physician, if wished by the participant.&lt;br /&gt;
&lt;br /&gt;
Venous blood sampling is performed. Approximately 70 ml of blood is drawn from a forearm vein, which corresponds to about the same volume as half a cup of coffee. Blood sugar level, cholesterol profile, electrolytes, whole blood count (including red and white blood cells and platelets) and liver-and kidney function tests are dosed in the blood on the same day, and results are mentioned in the medical report. More specialized tests such as dosage of hormones implemented in blood pressure regulation and renal sodium handling are performed in a later stage.&lt;br /&gt;
&lt;br /&gt;
In order to study the elastic properties of the arteries in a non-invasive way, a so called pulse wave analysis is performed, using a Sphygmocor device (AtCor Medical Pty. Ltd., West Ryde, Australia). [[File:sphigmo_carot.jpg|300px]]Briefly, a small tonometer measures elasticity of the right carotid, radial and femoral artery, by applying a little bit of pressure at the corresponding anatomical regions. Total duration of this exam is 15 minutes. The elasticity of the artery influences the pulse wave velocity (PWV), which on his term correlates with the global degree of atherosclerosis (‘calcification’ and formation of cholesterol deposits in of the artery wall) of the participant. Atherosclerosis is the main culprit of arterial narrowing and eventually occlusion, which leads to heart infarcts or cerebral infarcts, depending of which arteries are affected.[[File:sphigmo_rad.jpg|300px]]&lt;br /&gt;
&lt;br /&gt;
Besides, the Sphygmocor device provides an estimation of the blood pressure in the aorta (‘central blood pressure’). The central blood pressure is a more precise predictor of future cardiovascular events than the blood pressure measured at the arm, and experts believe that it will become an essential tool to take therapeutic decisions regarding blood pressure treatment in the future.&lt;br /&gt;
&lt;br /&gt;
Abdominal ultrasound is performed in every participant[[File:renalUS.jpg|300px]]. This is one of the reasons that participants should come after an overnight fast, since visibility is reduced after meals. The ultrasound exam is painless, free of irradiation, and without known side effects. Of note, it is the only radiological exam than can be safely performed throughout pregnancy. In SKIPOGH, the ultrasound focuses on the kidneys, since kidneys are key regulators of blood pressure. Kidney size, volume, and vascular properties are therefore measured in detail. Other organs such as the gallbladder, liver and prostate are briefly visualized, and an estimation of the aortic diameter assessed. In case of the detection of an anomaly (cyst, kidney stone, other), the participant as well as his/her treating physician is informed without delay.&lt;br /&gt;
After the abdominal ultrasound, a Diasys® device is installed on the non-dominant arm, which measures every 20-30 minutes the arterial blood pressure. The participant leaves the clinic with the Diasys® device, and will collect all urine produced the same day and night in two separate urine containers. Finally, a questionnaire is filled in at home by the participant (duration: 30 minutes). The questionnaire includes question s on previous medical history, medication intake, professional life, and life habits (alimentation, physical activity).&lt;br /&gt;
&lt;br /&gt;
The following day, a home visit is performed by a study nurse. Home blood pressure is measured five times, the questionnaire is revised by the research nurse, the Diasys® device removed and urinary containers collected. The research nurse will also hand over the medical report to the participant, mentioning that in case of questions, the participant should not hesitate to contact the responsible physician of the study center.&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Methods</id>
		<title>Methods</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Methods"/>
				<updated>2013-03-09T18:55:38Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Participants come to the study center on weekdays, in general between 8am-9am after an overnight fast. They are allowed to drink water and to take their usual medication. They are welcomed by one of the medical assistants or study nurses, and the study procedures are explained. Total duration of the ‘check-up’ is 2h-2h30. First of all, the blood pressure is measured on both arms as shown in figure 1.  For blood pressure&lt;br /&gt;
measurement, the A&amp;amp;D UM-101 (A&amp;amp;D Company, Ltd., Toshima Ku, Tokyo, Japan) is used, a non-mercury manual auscultatory sphygmomanometer. [[File:bp.jpg]]This device has the same precision as the classical mercury sphygmomanometer, and has replaced the latter for ecological reasons.&lt;br /&gt;
&lt;br /&gt;
Body weight and size are measured, followed by the abdominal circumference. Of note, measurement of these parameters are used-among others- to calculate the so called ‘Body Mass Index (formula= body weight (kg)/ (length in meters). The BMI allows the classification into different categories of weight:  &amp;lt;20 underweight, 20-25 normal, 25-30 overweight, and ≥30 obese.&lt;br /&gt;
&lt;br /&gt;
The hand grip strength of the right and left hand is measured three times with the ‘Baseline Hydraulic Hand Dynamometer®’ (see figure) with subjects in a standing position. Subjects hold the dynamometer at thigh level and are encouraged to exert the strongest possible force, each time for several seconds. Hand grip strength offers information on muscle mass and nutritional status. HSG is of special interest in older individuals (&amp;gt;65 years), since some studies have shown that reduced HSG is associated with an increased risk of mortality.&lt;br /&gt;
&lt;br /&gt;
Bioelectrical –impedance analysis (BIA) is a non-invasive technique which allows assessment of body composition (fat mass, muscle mass, hydration level) in a few seconds. [[File:electr.jpg]]Two electrodes are attached to the right hand and the right foot, and the bio-impedance (Ω) to a very weak electric current between the electrodes is measured, which allows on its term body composition assessment.  Moreover, basal metabolic rate and the estimated daily caloric need are calculated using an incorporated algorithm.&lt;br /&gt;
&lt;br /&gt;
An electrocardiogram (ECG) is obtained with the SDS-104 device from Schiller. ECG measures the electric activity of the heart, and provides essential information on heart functioning, such as heart rate, eventual ischemia (lack of oxygen) and/or hypertrophy (muscular over-development of the heart). The ECG is part of the medical report that is given to all participants the day after during the home visit, and a copy of the medical report is sent to the treating physician, if wished by the participant.&lt;br /&gt;
&lt;br /&gt;
Venous blood sampling is performed. Approximately 70 ml of blood is drawn from a forearm vein, which corresponds to about the same volume as half a cup of coffee. Blood sugar level, cholesterol profile, electrolytes, whole blood count (including red and white blood cells and platelets) and liver-and kidney function tests are dosed in the blood on the same day, and results are mentioned in the medical report. More specialized tests such as dosage of hormones implemented in blood pressure regulation and renal sodium handling are performed in a later stage.&lt;br /&gt;
&lt;br /&gt;
In order to study the elastic properties of the arteries in a non-invasive way, a so called pulse wave analysis is performed, using a Sphygmocor device (AtCor Medical Pty. Ltd., West Ryde, Australia). [[File:sphigmo_carot.jpg]]Briefly, a small tonometer measures elasticity of the right carotid, radial and femoral artery, by applying a little bit of pressure at the corresponding anatomical regions. Total duration of this exam is 15 minutes. The elasticity of the artery influences the pulse wave velocity (PWV), which on his term correlates with the global degree of atherosclerosis (‘calcification’ and formation of cholesterol deposits in of the artery wall) of the participant. Atherosclerosis is the main culprit of arterial narrowing and eventually occlusion, which leads to heart infarcts or cerebral infarcts, depending of which arteries are affected.[[File:sphigmo_rad.jpg]]&lt;br /&gt;
&lt;br /&gt;
Besides, the Sphygmocor device provides an estimation of the blood pressure in the aorta (‘central blood pressure’). The central blood pressure is a more precise predictor of future cardiovascular events than the blood pressure measured at the arm, and experts believe that it will become an essential tool to take therapeutic decisions regarding blood pressure treatment in the future.&lt;br /&gt;
&lt;br /&gt;
Abdominal ultrasound is performed in every participant[[File:renalUS.jpg]]. This is one of the reasons that participants should come after an overnight fast, since visibility is reduced after meals. The ultrasound exam is painless, free of irradiation, and without known side effects. Of note, it is the only radiological exam than can be safely performed throughout pregnancy. In SKIPOGH, the ultrasound focuses on the kidneys, since kidneys are key regulators of blood pressure. Kidney size, volume, and vascular properties are therefore measured in detail. Other organs such as the gallbladder, liver and prostate are briefly visualized, and an estimation of the aortic diameter assessed. In case of the detection of an anomaly (cyst, kidney stone, other), the participant as well as his/her treating physician is informed without delay.&lt;br /&gt;
After the abdominal ultrasound, a Diasys® device is installed on the non-dominant arm, which measures every 20-30 minutes the arterial blood pressure. The participant leaves the clinic with the Diasys® device, and will collect all urine produced the same day and night in two separate urine containers. Finally, a questionnaire is filled in at home by the participant (duration: 30 minutes). The questionnaire includes question s on previous medical history, medication intake, professional life, and life habits (alimentation, physical activity).&lt;br /&gt;
&lt;br /&gt;
The following day, a home visit is performed by a study nurse. Home blood pressure is measured five times, the questionnaire is revised by the research nurse, the Diasys® device removed and urinary containers collected. The research nurse will also hand over the medical report to the participant, mentioning that in case of questions, the participant should not hesitate to contact the responsible physician of the study center.&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/File:Sphigmo_rad.jpg</id>
		<title>File:Sphigmo rad.jpg</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/File:Sphigmo_rad.jpg"/>
				<updated>2013-03-09T18:52:49Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/File:Sphigmo_carot.jpg</id>
		<title>File:Sphigmo carot.jpg</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/File:Sphigmo_carot.jpg"/>
				<updated>2013-03-09T18:52:30Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/File:RenalUS.jpg</id>
		<title>File:RenalUS.jpg</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/File:RenalUS.jpg"/>
				<updated>2013-03-09T18:51:58Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/File:Electr.jpg</id>
		<title>File:Electr.jpg</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/File:Electr.jpg"/>
				<updated>2013-03-09T18:51:38Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/File:Bp.jpg</id>
		<title>File:Bp.jpg</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/File:Bp.jpg"/>
				<updated>2013-03-09T18:51:20Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/News</id>
		<title>News</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/News"/>
				<updated>2013-03-09T18:42:56Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;March 2013: '''1,134 participants have now been included!'''&lt;br /&gt;
&lt;br /&gt;
October 2012: '''Phase 2''' of the study (follow-up with additional exams) begins in Lausanne!&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/News</id>
		<title>News</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/News"/>
				<updated>2013-03-09T18:42:24Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;March 2013: '''1,134 participants have now been included!'''&lt;br /&gt;
&lt;br /&gt;
October 2012: Phase 2 of the study begins in Lausanne!&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Collaborations_and_publications</id>
		<title>Collaborations and publications</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Collaborations_and_publications"/>
				<updated>2013-03-09T18:41:12Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''2013'''&lt;br /&gt;
&lt;br /&gt;
Genes for blood pressure: an opportunity to understand hypertension. Ehret GB and Caulfield M. Eur Heart J. 2013[http://www.ncbi.nlm.nih.gov/pubmed/23303660]&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
'''2012'''&lt;br /&gt;
&lt;br /&gt;
Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension. Hum Mol Genet. 2012 Jul 15;21(14):3283-92. Guessous I, Dobrinas M, Kutalik Z, Pruijm M, Ehret G, Maillard M, Bergmann S, Beckmann JS, Cusi D, Rizzi F, Cappuccio F, Cornuz J, Paccaud F, Mooser V, Gaspoz JM, Waeber G, Burnier M, Vollenweider P, Eap CB, Bochud M.[http://www.ncbi.nlm.nih.gov/pubmed/22492992]&lt;br /&gt;
&lt;br /&gt;
A multi-SNP locus-association method reveals a substantial fraction of the missing heritability. Ehret GB, Lamparter D, Hoggart CJ; Genetic Investigation of Anthropometric Traits Consortium, Whittaker JC, Beckmann JS, Kutalik Z.Am J Hum Genet. 2012 Nov 2;91(5):863-71.[http://www.ncbi.nlm.nih.gov/pubmed/23122585]&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
'''2011'''&lt;br /&gt;
&lt;br /&gt;
Bochud M. et al., Eur J Public Health. 2011 Feb;21(1):5-6.[http://www.ncbi.nlm.nih.gov/pubmed/]&lt;br /&gt;
&lt;br /&gt;
Guessous I et al, Kidney Blood Press Res. 2011 Jun 11;34(6):404-417.[http://www.ncbi.nlm.nih.gov/pubmed/]&lt;br /&gt;
&lt;br /&gt;
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Ehret GB, Munroe PB, Rice KM, Bochud M et al. Nature. 2011 Sep 11;478(7367):103-9.[http://www.ncbi.nlm.nih.gov/pubmed/21909115]&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
'''2010'''&lt;br /&gt;
&lt;br /&gt;
Pruijm M et al, Blood Press Monit. 2010 Dec;15(6):322-5.[http://www.ncbi.nlm.nih.gov/pubmed/]&lt;br /&gt;
&lt;br /&gt;
Resistant Hypertension. Ehret GB, Pechère-Bertschi A. Rev Med Suisse. 2010 Sep 15;6(262):1721-2, 1724-7. [http://www.ncbi.nlm.nih.gov/pubmed/21294307]&lt;br /&gt;
&lt;br /&gt;
Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Ehret GB. Curr Hypertens Rep. 2010 Feb;12(1):17-25.[http://www.ncbi.nlm.nih.gov/pubmed/20425154]&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Centers</id>
		<title>Centers</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Centers"/>
				<updated>2013-03-09T18:38:33Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;More than 7000 persons have participated to EPOGH in Europe. EPOGH has resulted in over 100 scientific publications in the field of hypertension (high blood pressure) and genetics. It has substantially participated to the breakthrough established in 2009 in high blood pressure research, identifying 13 loci (regions of the chromosome) that are associated with high blood pressure. Of note, one of the SKIPOGH-investigators was first author of this paper.&lt;br /&gt;
&lt;br /&gt;
The goal of SKIPOGH is to screen 1200 Swiss inhabitants, from approximately 400 families. A simple, non stratified sample of subjects has been drawn from lists of inhabitants provided by the population registers of the three cities. A letter inviting the addressee to participate is sent, and subjects are contacted within 14 days by one of the staff members. The following inclusion criteria are applied: (a) written informed consent; (b) minimum age 18 years; (c) willingness to take part in the examination and donate blood sample; (d) Caucasian origin, defined as having both parents and grandparents born in a restricted list of countries (available from the authors) (e) at least one, and preferably three, first degree family members also willing to participate. The family members are contacted in a similar way, and an appointment for a study visit is set individually with each family member. The SKIPOGH study was approved by the Institutional Ethics Committee of the Universities of Bern, Geneva and Lausanne. SKIPOGH has started recruitment in January 2010. In July 2011, a total number of 600 persons was reached. Recruitment shall continue until April 2013.&lt;br /&gt;
&lt;br /&gt;
The SKIPOGH study has 4 field centers (Lausanne, Geneva, Bern, Zurich) and the data coordinating center in Lausanne.&lt;br /&gt;
&lt;br /&gt;
The [http://www.staessen.net European Coordinating Center] is in Leuven under the direction of Prof. Staessen.&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Centers</id>
		<title>Centers</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Centers"/>
				<updated>2013-03-09T18:38:18Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;More than 7000 persons have participated to EPOGH in Europe. EPOGH has resulted in over 100 scientific publications in the field of hypertension (high blood pressure) and genetics. It has substantially participated to the breakthrough established in 2009 in high blood pressure research, identifying 13 loci (regions of the chromosome) that are associated with high blood pressure. Of note, one of the SKIPOGH-investigators was first author of this paper.&lt;br /&gt;
&lt;br /&gt;
The goal of SKIPOGH is to screen 1200 Swiss inhabitants, from approximately 400 families. A simple, non stratified sample of subjects has been drawn from lists of inhabitants provided by the population registers of the three cities. A letter inviting the addressee to participate is sent, and subjects are contacted within 14 days by one of the staff members. The following inclusion criteria are applied: (a) written informed consent; (b) minimum age 18 years; (c) willingness to take part in the examination and donate blood sample; (d) Caucasian origin, defined as having both parents and grandparents born in a restricted list of countries (available from the authors) (e) at least one, and preferably three, first degree family members also willing to participate. The family members are contacted in a similar way, and an appointment for a study visit is set individually with each family member. The SKIPOGH study was approved by the Institutional Ethics Committee of the Universities of Bern, Geneva and Lausanne. SKIPOGH has started recruitment in January 2010. In July 2011, a total number of 600 persons was reached. Recruitment shall continue until April 2013.&lt;br /&gt;
&lt;br /&gt;
The SKIPOGH study has 4 field centers (Lausanne, Geneva, Bern, Zurich) and the data coordinating center in Lausanne.&lt;br /&gt;
&lt;br /&gt;
The [[http://www.staessen.net European Coordinating Center]] is in Leuven under the direction of Prof. Staessen.&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Centers</id>
		<title>Centers</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Centers"/>
				<updated>2013-03-09T18:37:58Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;More than 7000 persons have participated to EPOGH in Europe. EPOGH has resulted in over 100 scientific publications in the field of hypertension (high blood pressure) and genetics. It has substantially participated to the breakthrough established in 2009 in high blood pressure research, identifying 13 loci (regions of the chromosome) that are associated with high blood pressure. Of note, one of the SKIPOGH-investigators was first author of this paper.&lt;br /&gt;
&lt;br /&gt;
The goal of SKIPOGH is to screen 1200 Swiss inhabitants, from approximately 400 families. A simple, non stratified sample of subjects has been drawn from lists of inhabitants provided by the population registers of the three cities. A letter inviting the addressee to participate is sent, and subjects are contacted within 14 days by one of the staff members. The following inclusion criteria are applied: (a) written informed consent; (b) minimum age 18 years; (c) willingness to take part in the examination and donate blood sample; (d) Caucasian origin, defined as having both parents and grandparents born in a restricted list of countries (available from the authors) (e) at least one, and preferably three, first degree family members also willing to participate. The family members are contacted in a similar way, and an appointment for a study visit is set individually with each family member. The SKIPOGH study was approved by the Institutional Ethics Committee of the Universities of Bern, Geneva and Lausanne. SKIPOGH has started recruitment in January 2010. In July 2011, a total number of 600 persons was reached. Recruitment shall continue until April 2013.&lt;br /&gt;
&lt;br /&gt;
The SKIPOGH study has 4 field centers (Lausanne, Geneva, Bern, Zurich) and the data coordinating center in Lausanne.&lt;br /&gt;
&lt;br /&gt;
The [http://www.staessen.net | European Coordinating Center] is in Leuven under the direction of Prof. Staessen.&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Centers</id>
		<title>Centers</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Centers"/>
				<updated>2013-03-09T18:36:44Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;More than 7000 persons have participated to EPOGH in Europe. EPOGH has resulted in over 100 scientific publications in the field of hypertension (high blood pressure) and genetics. It has substantially participated to the breakthrough established in 2009 in high blood pressure research, identifying 13 loci (regions of the chromosome) that are associated with high blood pressure. Of note, one of the SKIPOGH-investigators was first author of this paper.&lt;br /&gt;
&lt;br /&gt;
The goal of SKIPOGH is to screen 1200 Swiss inhabitants, from approximately 400 families. A simple, non stratified sample of subjects has been drawn from lists of inhabitants provided by the population registers of the three cities. A letter inviting the addressee to participate is sent, and subjects are contacted within 14 days by one of the staff members. The following inclusion criteria are applied: (a) written informed consent; (b) minimum age 18 years; (c) willingness to take part in the examination and donate blood sample; (d) Caucasian origin, defined as having both parents and grandparents born in a restricted list of countries (available from the authors) (e) at least one, and preferably three, first degree family members also willing to participate. The family members are contacted in a similar way, and an appointment for a study visit is set individually with each family member. The SKIPOGH study was approved by the Institutional Ethics Committee of the Universities of Bern, Geneva and Lausanne. SKIPOGH has started recruitment in January 2010. In July 2011, a total number of 600 persons was reached. Recruitment shall continue until April 2013.&lt;br /&gt;
&lt;br /&gt;
The SKIPOGH study has 4 field centers (Lausanne, Geneva, Bern, Zurich) and the data coordinating center in Lausanne.&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Bruno_Vogt</id>
		<title>Bruno Vogt</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Bruno_Vogt"/>
				<updated>2013-03-09T18:35:18Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: Created page with &amp;quot;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt; {| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot; | style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top;...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:transparent&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&lt;br /&gt;
xxx&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:xx|200px]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Pierre-Yves_Martin</id>
		<title>Pierre-Yves Martin</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Pierre-Yves_Martin"/>
				<updated>2013-03-09T18:35:04Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: Created page with &amp;quot;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt; {| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot; | style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top;...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:transparent&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&lt;br /&gt;
xxx&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:xx|200px]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Michel_Burnier</id>
		<title>Michel Burnier</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Michel_Burnier"/>
				<updated>2013-03-09T18:34:36Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: Created page with &amp;quot;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt; {| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot; | style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top;...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:transparent&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&lt;br /&gt;
xxx&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:xx|200px]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/People</id>
		<title>People</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/People"/>
				<updated>2013-03-09T18:33:48Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Lausanne'''&lt;br /&gt;
&lt;br /&gt;
Prof. [[Murielle Bochud]], MD PhD, principal investigator&lt;br /&gt;
&lt;br /&gt;
Prof Michel Burnier, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof [[Fred Paccaud]], MD, investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Menno Pruijm]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Marie-Eve Müller, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Heba Al-Alwan, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Pierre Monney, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Sandrine Estoppey, MSc, coordinator&lt;br /&gt;
&lt;br /&gt;
Mrs Sylvie Tremblay, research nurse&lt;br /&gt;
&lt;br /&gt;
Mrs Güler Gök-Sogut, medical assistant&lt;br /&gt;
&lt;br /&gt;
Mrs [[Jacquier Filomena]], administrative assistant&lt;br /&gt;
&lt;br /&gt;
Mrs Renata Testaz, administrator&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Geneva'''&lt;br /&gt;
&lt;br /&gt;
Prof Pierre-Yves Martin, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof [[Antoinette Pechere | Antoinette Péchère-Bertschi]], MD, investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Belen Ponte]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Idris Guessous, MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr [[Georg Ehret]] MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Yassine Bouatou, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Stéphane Reverdin, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Marie-Odile Lévi, research nurse&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Bern'''&lt;br /&gt;
&lt;br /&gt;
Prof Bruno Vogt, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Markus Mohaupt, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Felix Frey, MD (retired), investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Daniel Ackermann]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Nasser Dahyat, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Ulla Schüpbach, research nurse&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Zurich'''&lt;br /&gt;
&lt;br /&gt;
Prof [[Olivier Devuyst]], MD&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Daniel_Ackermann</id>
		<title>Daniel Ackermann</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Daniel_Ackermann"/>
				<updated>2013-03-09T18:33:28Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: Created page with &amp;quot;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt; {| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot; | style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top;...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:transparent&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Daniel Ackermann is staff physician in Nephrology at the University of Bern.&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:DanielAckermann.jpg|200px]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Belen_Ponte</id>
		<title>Belen Ponte</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Belen_Ponte"/>
				<updated>2013-03-09T18:32:33Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:transparent&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Belen Ponte is staff physician in Nephrology at Geneva University Hospitals.&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:Ponte.jpg|200px]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/People</id>
		<title>People</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/People"/>
				<updated>2013-03-09T18:32:18Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Lausanne'''&lt;br /&gt;
&lt;br /&gt;
Prof. [[Murielle Bochud]], MD PhD, principal investigator&lt;br /&gt;
&lt;br /&gt;
Prof Michel Burnier, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Fred Paccaud, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Menno Pruijm]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Marie-Eve Müller, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Heba Al-Alwan, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Pierre Monney, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Sandrine Estoppey, MSc, coordinator&lt;br /&gt;
&lt;br /&gt;
Mrs Sylvie Tremblay, research nurse&lt;br /&gt;
&lt;br /&gt;
Mrs Güler Gök-Sogut, medical assistant&lt;br /&gt;
&lt;br /&gt;
Mrs [[Jacquier Filomena]], administrative assistant&lt;br /&gt;
&lt;br /&gt;
Mrs Renata Testaz, administrator&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Geneva'''&lt;br /&gt;
&lt;br /&gt;
Prof Pierre-Yves Martin, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof [[Antoinette Pechere | Antoinette Péchère-Bertschi]], MD, investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Belen Ponte]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Idris Guessous, MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr [[Georg Ehret]] MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Yassine Bouatou, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Stéphane Reverdin, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Marie-Odile Lévi, research nurse&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Bern'''&lt;br /&gt;
&lt;br /&gt;
Prof Bruno Vogt, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Markus Mohaupt, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Felix Frey, MD (retired), investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Daniel Ackermann]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Nasser Dahyat, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Ulla Schüpbach, research nurse&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Zurich'''&lt;br /&gt;
&lt;br /&gt;
Prof [[Olivier Devuyst]], MD&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/People</id>
		<title>People</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/People"/>
				<updated>2013-03-09T18:31:56Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Lausanne'''&lt;br /&gt;
&lt;br /&gt;
Prof. [[Murielle Bochud]], MD PhD, principal investigator&lt;br /&gt;
&lt;br /&gt;
Prof Michel Burnier, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Fred Paccaud, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Menno Pruijm]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Marie-Eve Müller, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Heba Al-Alwan, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Pierre Monney, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Sandrine Estoppey, MSc, coordinator&lt;br /&gt;
&lt;br /&gt;
Mrs Sylvie Tremblay, research nurse&lt;br /&gt;
&lt;br /&gt;
Mrs Güler Gök-Sogut, medical assistant&lt;br /&gt;
&lt;br /&gt;
Mrs [[Jacquier Filomena]], administrative assistant&lt;br /&gt;
&lt;br /&gt;
Mrs Renata Testaz, administrator&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Geneva'''&lt;br /&gt;
&lt;br /&gt;
Prof Pierre-Yves Martin, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof [[Antoinette Pechere | Antoinette Péchère-Bertschi]], MD, investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[BelenPonte | Belen Ponte]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Idris Guessous, MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr [[Georg Ehret]] MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Yassine Bouatou, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Stéphane Reverdin, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Marie-Odile Lévi, research nurse&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Bern'''&lt;br /&gt;
&lt;br /&gt;
Prof Bruno Vogt, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Markus Mohaupt, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Felix Frey, MD (retired), investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Daniel Ackermann]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Nasser Dahyat, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Ulla Schüpbach, research nurse&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Zurich'''&lt;br /&gt;
&lt;br /&gt;
Prof [[Olivier Devuyst]], MD&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/People</id>
		<title>People</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/People"/>
				<updated>2013-03-09T18:31:25Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Lausanne'''&lt;br /&gt;
&lt;br /&gt;
Prof. [[Murielle Bochud]], MD PhD, principal investigator&lt;br /&gt;
&lt;br /&gt;
Prof Michel Burnier, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Fred Paccaud, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Menno Pruijm]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Marie-Eve Müller, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Heba Al-Alwan, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Pierre Monney, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Sandrine Estoppey, MSc, coordinator&lt;br /&gt;
&lt;br /&gt;
Mrs Sylvie Tremblay, research nurse&lt;br /&gt;
&lt;br /&gt;
Mrs Güler Gök-Sogut, medical assistant&lt;br /&gt;
&lt;br /&gt;
Mrs [[Jacquier Filomena]], administrative assistant&lt;br /&gt;
&lt;br /&gt;
Mrs Renata Testaz, administrator&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Geneva'''&lt;br /&gt;
&lt;br /&gt;
Prof Pierre-Yves Martin, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof [[Antoinette Pechere | Antoinette Péchère-Bertschi]], MD, investigator&lt;br /&gt;
&lt;br /&gt;
Dr [BelenPonte | Belen Ponte]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Idris Guessous, MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr [[Georg Ehret]] MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Yassine Bouatou, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Stéphane Reverdin, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Marie-Odile Lévi, research nurse&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Bern'''&lt;br /&gt;
&lt;br /&gt;
Prof Bruno Vogt, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Markus Mohaupt, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Felix Frey, MD (retired), investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Daniel Ackermann]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Nasser Dahyat, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Ulla Schüpbach, research nurse&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Zurich'''&lt;br /&gt;
&lt;br /&gt;
Prof [[Olivier Devuyst]], MD&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Jacquier_Filomena</id>
		<title>Jacquier Filomena</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Jacquier_Filomena"/>
				<updated>2013-03-09T18:30:47Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: Created page with &amp;quot;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt; {| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot; | style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top;...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:transparent&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Filomena Jacquier is personal assistant to Prof. Murielle Bochud.&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:MenaJacquier.jpg|200px]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Murielle_Bochud</id>
		<title>Murielle Bochud</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Murielle_Bochud"/>
				<updated>2013-03-09T18:30:04Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:transparent&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Murielle Bochud holds a diploma in medicine from the University of Geneva (Switzerland, 1994), an MD from the University of Lausanne (Switzerland, 2002) and a PhD in genetic epidemiology from Case University (2007, Cleveland, USA). She currently works as an assistant professor at the University Institute of Social and Preventive Medicine in Lausanne, Switzerland. Her research focuses on the epidemiology of chronic disease and, particularly, the genetics of blood pressure, renal function and obesity, based on population and family based data. She participates in international genome-wide meta-analyses such as the Global BPGen, the ICBP, the CKDGen Consortia as well as projects aimed at deciphering the genetic determinants of infectious diseases. Her work is based on a multidisciplinary approach with epidemiologists, public health specialists, clinicians, geneticists, statisticians, bioinformaticians and molecular biologists. With the explosion of genomic discoveries on common complex traits, she is interested in developing the new field of public health genomics, which attempts to translate molecular findings into clinical and public health applications, and vice versa.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:MurielleBochud.jpg|200px]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Olivier_Devuyst</id>
		<title>Olivier Devuyst</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Olivier_Devuyst"/>
				<updated>2013-03-09T18:29:41Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:transparent&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Olivier Devuyst, MD, PhD, is Full Professor in the Institute of Physiology of the UZH and invited Professor at the Université catholique de Louvain (UCL) Medical School in Brussels, Belgium. He has a joint appointment in the Division of Nephrology of the USZ in Zurich and the Saint-Luc Academic Hospital in Brussels.&lt;br /&gt;
Dr. Devuyst and his group investigate the molecular mechanisms of the transport of water and solutes across epithelia, and the pathophysiology of inherited renal tubular diseases and their progression. He also launched a systematic approach of the molecular mechanisms involved in the transport of water and solutes across the peritoneal membrane, which is relevant to understand - and hopefully improve- peritoneal dialysis. &lt;br /&gt;
Dr. Devuyst has given more than 160 invited lectures  and has been the laureate of several international prizes. He has been elected at the Royal Academy of Medicine of Belgium in 2005. Dr. Devuyst is Associate Editor of Peritoneal Dialysis International and Nephrology Dialysis Transplantation, and he serves in the Editorial Board of Kidney International, Pflügers Archiv and  Frontiers in Renal and Epithelial Physiology. He coordinates EUNEFRON, the European Network for the Study of Orphan Nephropathies, and is President of the Working Group on Inherited Kidney Disorders (WGIKD) of the European Renal Association (ERA-EDTA).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:ODevuyst.jpg|200px]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Olivier_Devuyst</id>
		<title>Olivier Devuyst</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Olivier_Devuyst"/>
				<updated>2013-03-09T18:29:23Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:transparent&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Olivier Devuyst, MD, PhD, is Full Professor in the Institute of Physiology of the UZH and invited Professor at the Université catholique de Louvain (UCL) Medical School in Brussels, Belgium. He has a joint appointment in the Division of Nephrology of the USZ in Zurich and the Saint-Luc Academic Hospital in Brussels.&lt;br /&gt;
Dr. Devuyst and his group investigate the molecular mechanisms of the transport of water and solutes across epithelia, and the pathophysiology of inherited renal tubular diseases and their progression. He also launched a systematic approach of the molecular mechanisms involved in the transport of water and solutes across the peritoneal membrane, which is relevant to understand - and hopefully improve- peritoneal dialysis. &lt;br /&gt;
Dr. Devuyst has given more than 160 invited lectures  and has been the laureate of several international prizes. He has been elected at the Royal Academy of Medicine of Belgium in 2005. Dr. Devuyst is Associate Editor of Peritoneal Dialysis International and Nephrology Dialysis Transplantation, and he serves in the Editorial Board of Kidney International, Pflügers Archiv and  Frontiers in Renal and Epithelial Physiology. He coordinates EUNEFRON, the European Network for the Study of Orphan Nephropathies, and is President of the Working Group on Inherited Kidney Disorders (WGIKD) of the European Renal Association (ERA-EDTA).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:OlivierDevuyst.jpg|200px]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/People</id>
		<title>People</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/People"/>
				<updated>2013-03-09T18:28:37Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;'''Lausanne'''&lt;br /&gt;
&lt;br /&gt;
Prof. [[Murielle Bochud]], MD PhD, principal investigator&lt;br /&gt;
&lt;br /&gt;
Prof Michel Burnier, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Fred Paccaud, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Menno Pruijm]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Marie-Eve Müller, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Heba Al-Alwan, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Pierre Monney, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Sandrine Estoppey, MSc, coordinator&lt;br /&gt;
&lt;br /&gt;
Mrs Sylvie Tremblay, research nurse&lt;br /&gt;
&lt;br /&gt;
Mrs Güler Gök-Sogut, medical assistant&lt;br /&gt;
&lt;br /&gt;
Mrs [[Jacquier Filomena]], administrative assistant&lt;br /&gt;
&lt;br /&gt;
Mrs Renata Testaz, administrator&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Geneva'''&lt;br /&gt;
&lt;br /&gt;
Prof Pierre-Yves Martin, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof [[Antoinette Péchère-Bertschi]], MD, investigator&lt;br /&gt;
&lt;br /&gt;
Dr [BelenPonte | Belen Ponte]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Idris Guessous, MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr [[Georg Ehret]] MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Yassine Bouatou, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Dr Stéphane Reverdin, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Marie-Odile Lévi, research nurse&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Bern'''&lt;br /&gt;
&lt;br /&gt;
Prof Bruno Vogt, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Markus Mohaupt, MD, investigator&lt;br /&gt;
&lt;br /&gt;
Prof Felix Frey, MD (retired), investigator&lt;br /&gt;
&lt;br /&gt;
Dr [[Daniel Ackermann]], MD, SPUM fellow (SKIPOGH-1)&lt;br /&gt;
&lt;br /&gt;
Dr Nasser Dahyat, MD, SPUM fellow (SKIPOGH-2)&lt;br /&gt;
&lt;br /&gt;
Mrs Ulla Schüpbach, research nurse&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Zurich'''&lt;br /&gt;
&lt;br /&gt;
Prof [[Olivier Devuyst]], MD&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Antoinette_Pechere</id>
		<title>Antoinette Pechere</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Antoinette_Pechere"/>
				<updated>2013-03-09T18:27:30Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: Created page with &amp;quot;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt; {| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot; | style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top;...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:transparent&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Prof. Pechère is head of the Hypertension Unit at Geneva University Hospitals.&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:AntoinettePechere.jpg|200px]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Menno_Pruijm</id>
		<title>Menno Pruijm</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Menno_Pruijm"/>
				<updated>2013-03-09T18:26:29Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:transparent&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Menno Pruijm is staff physician in Nephrology at Lausanne University Hospitals. &lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:MennPrium.jpg|200px]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	<entry>
		<id>http://www.skipogh.ch/index.php/Menno_Pruijm</id>
		<title>Menno Pruijm</title>
		<link rel="alternate" type="text/html" href="http://www.skipogh.ch/index.php/Menno_Pruijm"/>
				<updated>2013-03-09T18:26:17Z</updated>
		
		<summary type="html">&lt;p&gt;Gehret: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;!-- =============== COLONNE GAUCHE ================= --&amp;gt;&lt;br /&gt;
{| style=&amp;quot;margin-top:10px; background:transparent;&amp;quot;&lt;br /&gt;
| style=&amp;quot;width:65%; border:1px solid #a7d7f9; vertical-align:top; color:#000; padding: 0px 10px 10px 0px; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px;background:transparent&amp;quot; |&lt;br /&gt;
{| cellpadding=&amp;quot;2&amp;quot; cellspacing=&amp;quot;5&amp;quot; style=&amp;quot;width:100%; vertical-align:top; background:transparent;&amp;quot;&lt;br /&gt;
&lt;br /&gt;
Menno Pruijm is staff physician in Nephrology at Lausanne University Hospitals. &lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE GAUCHE =============== --&amp;gt;&lt;br /&gt;
|}&lt;br /&gt;
|&amp;lt;!-- ESPACE ENTRE LES 2 COLONNES --&amp;gt;  style=&amp;quot;border:5px solid transparent;&amp;quot; |&lt;br /&gt;
&amp;lt;!-- =================== COLONNE DROITE ================ --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[File:MennPrium.jpg|200px|]]&lt;br /&gt;
&amp;lt;!-- =============== FIN COLONNE DE DROITE =============== --&amp;gt;&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Gehret</name></author>	</entry>

	</feed>